SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anonymous who wrote (598)10/26/2001 1:45:34 AM
From: eric ross  Read Replies (1) of 656
 
I think IMNX is a good investment as compared to other big biotech firms who got no earnings yet command a higher price. Considering the anticipated FDA approval of ENBREL as psoriatic arthritis drug come middle of January, will enable IMNX to hold steady or most likely advance from its present price till January. And if Rhode Island plant is on target, the rest of 2002 will be financially rewarding.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News